General Catalyst Group XIII Files D, Exempt Offering Under 3(c)(7)

TL;DR

**General Catalyst Group XIII is a private fund raising money from big-time investors, not for public trading.**

AI Summary

General Catalyst Group XIII, L.P. filed a Form D on March 24, 2026, indicating a notice of an exempt offering of securities. This filing specifies that the company operates under Section 3(c)(7) of the Investment Company Act, meaning it is a private investment fund that sells securities only to qualified purchasers. For investors, this matters because it signals that General Catalyst Group XIII, L.P. is raising capital from sophisticated investors, which is typical for private equity or venture capital funds, and it is not a publicly traded company directly accessible to retail investors.

Why It Matters

This filing confirms General Catalyst Group XIII, L.P. is a private fund raising capital from qualified purchasers, not a public company, which means its shares are not available for typical stock market investors.

Risk Assessment

Risk Level: low — This is a routine administrative filing for a private fund and does not indicate any direct risk to public market investors.

Analyst Insight

This filing is primarily informational for regulatory purposes and does not provide direct actionable insights for public stock market investors, as General Catalyst Group XIII, L.P. is a private fund.

Key Players & Entities

• General Catalyst Group XIII, L.P. (company) — the filer of the Form D
• 0002106576 (company) — the CIK (Central Index Key) of the filer
• 2026-03-24 (date) — the filing date and effectiveness date of the Form D
• Section 3(c)(7) (other) — the specific exemption under the Investment Company Act

FAQ

Key Financial Figures

• $1 — enues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,
• $1,000,000 — No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,
• $5,000,000 — Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001
• $1,000,001 — e   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000
• $5,000,001 — $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000
• $25,000,000 — $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001
• $25,000,001 — $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,0
• $50,000,000 — 5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,0
• $100,000,000 — 25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $1
• $50,000,001 — 0,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   O

Filing Documents

• primary_doc.html (D)
• primary_doc.xml (D) — 15KB
• 0002106576-26-000001.txt ( ) — 16KB

From the Filing

Form D FORM D Notice of Exempt Offering of Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. OMB APPROVAL OMB Number: 3235-0076 Estimated Average burden hours per response: 4.0 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) None Entity Type Corporation Limited Partnership   Limited Liability Company   General Partnership   Business Trust Other   Name of Issuer   General Catalyst Group XIII, L.P. Jurisdiction of Incorporation/Organization DELAWARE   Year of Incorporation/Organization Over Five Years Ago Within Last Five Years (Specify Year) 2026 Yet to Be Formed           2. Principal Place of Business and Contact Information Name of Issuer   General Catalyst Group XIII, L.P. Street Address 1 Street Address 2   20 UNIVERSITY ROAD, 4TH FLOOR     CAMBRIDGE   MASSACHUSETTS     02138   617-234-7000   3. Related Persons Last Name First Name Middle Name General Catalyst Partners XIII, L.P. N/A Street Address 1 Street Address 2   20 University Road, 4th Floor       Cambridge   MASSACHUSETTS   02138   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) General Partner of the Issuer Last Name First Name Middle Name General Catalyst GP XIII, LLC N/A Street Address 1 Street Address 2   20 University Road, 4th Floor       Cambridge   MASSACHUSETTS   02138   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) General Partner of the Issuer's General Partner Last Name First Name Middle Name General Catalyst Group Management, LLC N/A Street Address 1 Street Address 2   20 University Road, 4th Floor       Cambridge   MASSACHUSETTS   02138   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Investment manager of the Issuer Last Name First Name Middle Name Taneja Hemant Street Address 1 Street Address 2   75 Hawthorne Street, 20th Floor       San Francisco   CALIFORNIA   94105   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Member of the GP of the Manager of the UGP of the Issuer Last Name First Name Middle Name Fialkow David P. Street Address 1 Street Address 2   20 University Road, 4th Floor       Cambridge   MASSACHUSETTS   02138   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Member of the GP of the Manager of the UGP of the Issuer Last Name First Name Middle Name Chenault Kenneth Street Address 1 Street Address 2   148 Lafayette Street,11th Floor       New York   NEW YORK   10013   Relationship: Executive Officer Director Promoter Clarification of Response (if Necessary) Member of the GP of the Manager of the UGP of the Issuer 4. Industry Group   Agriculture Banking & Financial Services     Commercial Banking     Insurance   Investing     Investment Banking     Pooled Investment Fund Hedge Fund Other Investment Fund Private Equity Fund Venture Capital Fund *Is the issuer registered as an investment company under the Investment Company Act of 1940? Yes  No   Other Banking & Financial Services   Business Services Energy     Coal Mining     Electric Utilities     Energy Conservation     Environmental Services     Oil & Gas     Other Energy Health Care     Biotechnology     Health Insurance     Hospitals & Physicians     Pharmaceuticals     Other Health Care                         Manufacturing Real Estate   Commercial   Construction   REITS & Finance   Residential Other Real Estate   Retailing Restaurants Technology   Computers   Telecommunications   Other Technology Travel   Airlines & Airports   Lodging & Conventions   Tourism & Travel Services   Other Travel Other        5. Issuer Size Revenue Range Aggregate Net Asset Value Range No Revenues   No Aggregate Net Asset Value   $1 - $1,000,000 $1 - $5,000,000   $1,000,001 - $5,000,000   $5,000,001 - $25,000,000 $5,000,001 - $25,000,000   $25,000,001 - $50,000,000 $25,000,001 - $100,000,000   $50,000,001 - $100,000,000   Over $100,000,000   Over $100,000,000   Decline to Disclose   Decline to Disclose   Not Applicable   Not Applicable   6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply) Rule 504(b)(1) (not (i), (ii) or (iii)) Rule 506(b)         Rule 504 (b)(1)(i) Rule 506(c) Rule 504 (b)(1)(ii) Securities Act Section 4(a)(5) Rule 504 (b)(1)(iii) Investment Company Act Section 3(c) Section 3(c)(1) Section 3(c)(9) Section 3(c)(2) Section 3(c)(10) Section 3(c)(3) Section 3(c)(11) Section 3(c)(4) Section 3(c)(12) Section 3(c)(5) Section 3(c)(13) Section 3(c)(6) Section 3(c)(14) Section 3(c)(7)     7. Type of Filing   New Notice Date of First Sale       First Sale Yet to Occur   Amendment     8. Duration of Offering Does the Issuer intend this offering to last more t

View Full Filing

View this D filing on SEC EDGAR